Frankenfield Christopher James — insider trades

Stock trades Frankenfield Christopher James reported on SEC Form 4 at XLO Xilio Therapeutics, Inc..

• Jan 2, 2026: sold 7,030 shares of XLO Xilio Therapeutics, Inc. ($4.50K)
• Jan 2, 2025: sold 6,954 shares of XLO Xilio Therapeutics, Inc. ($6.82K)